Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

Example Group: Participants_in_Anticoagulation_for_COVID_19_Combined_ATTACC_ACTIV_4a_and_REMAP_CAP_RCT_hospitalized_not_critically_ill

Generated Narrative: Group

Resource Group "7750" Version "8" Updated "2023-12-05 12:59:21+0000"

Artifact related artifact:

Artifact URL: https://fevir.net/resources/Group/7750

Artifact Date: 2022-01-11 17:20:56+0000

Artifact Publisher: Computable Publishing LLC

Artifact Copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/

Artifact Contact: support@computablepublishing.com

Artifact Author: Brian S. Alper:

CombinationMethod: all-of

modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]

identifier: FEvIR Object Identifier: 7750

type: person

membership: enumerated

name: Participants_in_Anticoagulation_for_COVID_19_Combined_ATTACC_ACTIV_4a_and_REMAP_CAP_RCT_hospitalized_not_critically_ill

description: An enumerated group participating in a randomized trial.

quantity: 2244

characteristic

CharacteristicDescription: Participant in the Anticoagulation for COVID-19 Combined (ATTACC, ACTIV-4a, and REMAP-CAP) RCT

code: Research Study for which this is the observed sample ()

value: Citation/7636: Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 [Journal Article]. Contributors: The ATTACC, ACTIV-4a, and REMAP-CAP Investigators. In: The New England Journal of Medicine, DOI 10.1056/NEJMoa2105911. Published August 04, 2021. Available at: https://doi.org/10.1056/NEJMoa2105911.

exclude: false

characteristic

CharacteristicDescription: Hospitalized

code: Admission to establishment (procedure) (SNOMED CT#305335007)

value: Hospital admission (SNOMED CT#32485007)

exclude: false

characteristic

CharacteristicDescription: COVID-19

code: Disease (disorder) (SNOMED CT#64572001)

value: ATTACC and ACTIV-4a limited inclusion to patients with confirmed COVID-19 (and excluded initially entered participants who did not have confirmed SARS-CoV-2. REMAP-CAP however included patients with confirmed COVID-19 or suspected COVID-19 with intent to test for COVID-19. (SNOMED CT#840539006 "Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)")

exclude: false

characteristic

CharacteristicDescription: not critically ill

code: Severity (SNOMED CT#246112005)

value: severe disease defined as ICU-level care or critically ill where ICU-level care was defined as the use of respiratory or cardiovascular organ support (oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes) (SNOMED CT#442452003 "Life threatening severity")

exclude: true